Crossmark

Association between tenofovir plasma trough concentrations in the early stage of administration and discontinuation of up to five years tenofovir disoproxil fumarate due to renal function-related adverse events in Japanese HIV-1 infected patients

Crossref DOI link: https://doi.org/10.1186/s40780-024-00343-z

Published Online: 2024-05-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yagura, Hiroki http://orcid.org/0000-0003-1613-8832
Watanabe, Dai

Nakauchi, Takao

Kushida, Hiroyuki

Hirota, Kazuyuki

Nishida, Yasuharu

Yoshino, Munehiro

Uehira, Tomoko

Shirasaka, Takuma
Funding

Funding for this research was provided by:

the Japan Agency for Medical Research and Development (JP23fk0410050)
License Information

Text and Data Mining valid from 2024-05-10

Version of Record valid from 2024-05-10
More Information

Article History

Received: 29 February 2024

Accepted: 6 May 2024

First Online: 10 May 2024

Declarations

:

: The study protocol was reviewed and approved by the Institutional Review Board of the Osaka National Hospital (approval no. 13058). The procedures were carried out in accordance with relevant guidelines and regulations. All samples were collected after acquiring written consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below